198 related articles for article (PubMed ID: 27875305)
1. (-)-Englerin A-evoked Cytotoxicity Is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase.
Ludlow MJ; Gaunt HJ; Rubaiy HN; Musialowski KE; Blythe NM; Vasudev NS; Muraki K; Beech DJ
J Biol Chem; 2017 Jan; 292(2):723-731. PubMed ID: 27875305
[TBL] [Abstract][Full Text] [Related]
2. Na
Muraki K; Ohnishi K; Takezawa A; Suzuki H; Hatano N; Muraki Y; Hamzah N; Foster R; Waldmann H; Nussbaumer P; Christmann M; Bon RS; Beech DJ
Sci Rep; 2017 Dec; 7(1):16988. PubMed ID: 29209034
[TBL] [Abstract][Full Text] [Related]
3. Identification of an (-)-englerin A analogue, which antagonizes (-)-englerin A at TRPC1/4/5 channels.
Rubaiy HN; Seitz T; Hahn S; Choidas A; Habenberger P; Klebl B; Dinkel K; Nussbaumer P; Waldmann H; Christmann M; Beech DJ
Br J Pharmacol; 2018 Mar; 175(5):830-839. PubMed ID: 29247460
[TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype.
Grant CV; Carver CM; Hastings SD; Ramachandran K; Muniswamy M; Risinger AL; Beutler JA; Mooberry SL
Breast Cancer Res Treat; 2019 Sep; 177(2):345-355. PubMed ID: 31230251
[TBL] [Abstract][Full Text] [Related]
5. Englerin A Inhibits T-Type Voltage-Gated Calcium Channels at Low Micromolar Concentrations.
Wardas B; Schneider JG; Klugbauer N; Flockerzi V; Beck A
Mol Pharmacol; 2023 Oct; 104(4):144-153. PubMed ID: 37399325
[TBL] [Abstract][Full Text] [Related]
6. (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.
Akbulut Y; Gaunt HJ; Muraki K; Ludlow MJ; Amer MS; Bruns A; Vasudev NS; Radtke L; Willot M; Hahn S; Seitz T; Ziegler S; Christmann M; Beech DJ; Waldmann H
Angew Chem Int Ed Engl; 2015 Mar; 54(12):3787-91. PubMed ID: 25707820
[TBL] [Abstract][Full Text] [Related]
7. Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.
Carson C; Raman P; Tullai J; Xu L; Henault M; Thomas E; Yeola S; Lao J; McPate M; Verkuyl JM; Marsh G; Sarber J; Amaral A; Bailey S; Lubicka D; Pham H; Miranda N; Ding J; Tang HM; Ju H; Tranter P; Ji N; Krastel P; Jain RK; Schumacher AM; Loureiro JJ; George E; Berellini G; Ross NT; Bushell SM; Erdemli G; Solomon JM
PLoS One; 2015; 10(6):e0127498. PubMed ID: 26098886
[TBL] [Abstract][Full Text] [Related]
8. Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels.
Rubaiy HN; Ludlow MJ; Siems K; Norman K; Foster R; Wolf D; Beutler JA; Beech DJ
Br J Pharmacol; 2018 Aug; 175(16):3361-3368. PubMed ID: 29859013
[TBL] [Abstract][Full Text] [Related]
9. Potent, selective, and subunit-dependent activation of TRPC5 channels by a xanthine derivative.
Minard A; Bauer CC; Chuntharpursat-Bon E; Pickles IB; Wright DJ; Ludlow MJ; Burnham MP; Warriner SL; Beech DJ; Muraki K; Bon RS
Br J Pharmacol; 2019 Oct; 176(20):3924-3938. PubMed ID: 31277085
[TBL] [Abstract][Full Text] [Related]
10. Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels.
Rubaiy HN; Ludlow MJ; Henrot M; Gaunt HJ; Miteva K; Cheung SY; Tanahashi Y; Hamzah N; Musialowski KE; Blythe NM; Appleby HL; Bailey MA; McKeown L; Taylor R; Foster R; Waldmann H; Nussbaumer P; Christmann M; Bon RS; Muraki K; Beech DJ
J Biol Chem; 2017 May; 292(20):8158-8173. PubMed ID: 28325835
[TBL] [Abstract][Full Text] [Related]
11. TRPC1 as a negative regulator for TRPC4 and TRPC5 channels.
Kim J; Ko J; Myeong J; Kwak M; Hong C; So I
Pflugers Arch; 2019 Aug; 471(8):1045-1053. PubMed ID: 31222490
[TBL] [Abstract][Full Text] [Related]
12. During post-natal human myogenesis, normal myotube size requires TRPC1- and TRPC4-mediated Ca²⁺ entry.
Antigny F; Koenig S; Bernheim L; Frieden M
J Cell Sci; 2013 Jun; 126(Pt 11):2525-33. PubMed ID: 23549783
[TBL] [Abstract][Full Text] [Related]
13. The Na+/K+-ATPase and the amyloid-beta peptide aβ1-40 control the cellular distribution, abundance and activity of TRPC6 channels.
Chauvet S; Boonen M; Chevallet M; Jarvis L; Abebe A; Benharouga M; Faller P; Jadot M; Bouron A
Biochim Biophys Acta; 2015 Nov; 1853(11 Pt A):2957-65. PubMed ID: 26348127
[TBL] [Abstract][Full Text] [Related]
14. Interaction between TRPC1/TRPC4 assembly and STIM1 contributes to store-operated Ca2+ entry in mesangial cells.
Sours-Brothers S; Ding M; Graham S; Ma R
Exp Biol Med (Maywood); 2009 Jun; 234(6):673-82. PubMed ID: 19307462
[TBL] [Abstract][Full Text] [Related]
15. TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis.
Zeng B; Yuan C; Yang X; Atkin SL; Xu SZ
Curr Cancer Drug Targets; 2013 Jan; 13(1):103-16. PubMed ID: 22920441
[TBL] [Abstract][Full Text] [Related]
16. Canonical transient receptor potential (TRPC) 1 acts as a negative regulator for vanilloid TRPV6-mediated Ca2+ influx.
Schindl R; Fritsch R; Jardin I; Frischauf I; Kahr H; Muik M; Riedl MC; Groschner K; Romanin C
J Biol Chem; 2012 Oct; 287(42):35612-35620. PubMed ID: 22932896
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants mediating gating of Transient Receptor Potential Canonical (TRPC) channels by stromal interaction molecule 1 (STIM1).
Lee KP; Choi S; Hong JH; Ahuja M; Graham S; Ma R; So I; Shin DM; Muallem S; Yuan JP
J Biol Chem; 2014 Mar; 289(10):6372-6382. PubMed ID: 24464579
[TBL] [Abstract][Full Text] [Related]
18. SARAF modulates TRPC1, but not TRPC6, channel function in a STIM1-independent manner.
Albarrán L; López JJ; Gómez LJ; Salido GM; Rosado JA
Biochem J; 2016 Oct; 473(20):3581-3595. PubMed ID: 27506849
[TBL] [Abstract][Full Text] [Related]
19. Functional expression of calcium-permeable canonical transient receptor potential 4-containing channels promotes migration of medulloblastoma cells.
Wei WC; Huang WC; Lin YP; Becker EBE; Ansorge O; Flockerzi V; Conti D; Cenacchi G; Glitsch MD
J Physiol; 2017 Aug; 595(16):5525-5544. PubMed ID: 28627017
[TBL] [Abstract][Full Text] [Related]
20. TRPC1 is involved in Ca²⁺ influx and cytotoxicity following Pb²⁺ exposure in human embryonic kidney cells.
Zhang H; Li W; Xue Y; Zou F
Toxicol Lett; 2014 Aug; 229(1):52-8. PubMed ID: 24953315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
